{"id":"W4385476635","doi":"10.1177/11795549231187264","title":"Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer","year":2023,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ovarian cancer; Medicine; Monoclonal antibody; Oncology; Cancer; Chemotherapy; Cytotoxic T cell; Internal medicine; Drug resistance; Antibody; Immunology; Cancer research; Biology; In vitro","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.001443424,0.0009907277,0.009890564,0.0009161509,0.00008722658,0.00001354456,0.0004123811,0.002062832,0.001635464],"category_scores_gemma":[0.001937984,0.0006088722,0.0008076848,0.001628006,0.0008352108,0.00005383437,0.0001962134,0.00237474,0.000596886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001813004,"about_ca_system_score_gemma":0.004261167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001150062,"about_ca_topic_score_gemma":0.003154328,"domain_scores_codex":[0.9913167,0.0009913791,0.004597106,0.001662577,0.0006031095,0.0008291202],"domain_scores_gemma":[0.9906905,0.005845834,0.001285912,0.001184952,0.0002216076,0.0007711525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003238627,0.001581389,0.0001426897,0.007438236,0.001280229,0.007816833,0.0001494373,2.82341e-7,4.264286e-7,0.0009322191,0.01843758,0.9618968],"study_design_scores_gemma":[0.009946292,0.005300754,0.00133305,0.04843403,0.00533355,0.0001271056,0.00004159228,0.000008451903,2.299131e-7,0.0004470537,0.9285605,0.0004673932],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005151208,0.9714669,0.00000601383,0.01085308,0.004622119,0.002936721,0.00007813714,0.0001890252,0.009796497],"genre_scores_gemma":[0.00006094856,0.9888129,0.0002785973,0.002027153,0.005194285,0.001180555,0.0004612353,0.0002178283,0.001766518],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9614294,"threshold_uncertainty_score":0.9999268,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3221679591626192,"score_gpt":0.5417869366401211,"score_spread":0.2196189774775019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}